The Latest Breaking News from CVS Health

UnitedHealth, Humana and other big health insurers fell Monday night on lower-than-expected Medicare Advantage rates for 2025.

CVS Health's Q4 results show growth potential despite stock volatility. Valuation suggests room for growth. Consider performance relative to peers for inve...

Here are the women, who are forging paths and breaking barriers across industries, showcasing exceptional leadership and innovation.

CVS Health reports strong revenue but slashes full-year profit outlook due to surging medical costs.

The largest U.S. drugstore chain, CVS Health (CVS), will release its fourth-quarter results on February 7. The company is expected to report year-over-year growth in revenue and earnings. With the expected rise in medical costs during the fourth quarter, should investors consider buying the stock now? Read on to learn…

The health insurer says 2024 earnings will be barely half of estimates due to higher Medicare Advantage costs.

CVS loyalty program members will now have two tiers of 'ExtraCare' benefits to choose from.

Enrollment in Medicare Advantage plans has outpaced expectations, but people should use caution when viewing these plans, expert says.

Looking ahead, 2024 likely will be filled with volatility, uncertainty, complexity, and ambiguity. That’s "VUCA" for you.

Three major pharmacy chains admitted to encouraging staff to hand prescription records over to law enforcement without a warrant, and without a legal review.

CVS Health is introducing changes to how its prescription drug pricing model works, and that could lead to some savings for customers starting next year